ODONATE THERAPEUTICS, INC.

(ODTC)
  Report
Delayed OTC Markets  -  05/18 09:49:31 am EDT
1.500 USD   -1.32%
05/13NORTH AMERICAN MORNING BRIEFING : Tech Futures -2-
DJ
04/12NORTH AMERICAN MORNING BRIEFING : Stocks Waver, -3-
DJ
02/22NORTH AMERICAN MORNING BRIEFING : Stocks to Open -3-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Odonate Therapeutics Gets Nasdaq Notice to Delist Shares

01/07/2022 | 09:31am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
NASDAQ COMP. -1.72% 11779.15 Real-time Quote.-23.40%
ODONATE THERAPEUTICS, INC. -1.32% 1.5 Delayed Quote.12.59%
All news about ODONATE THERAPEUTICS, INC.
05/13NORTH AMERICAN MORNING BRIEFING : Tech Futures -2-
DJ
04/12NORTH AMERICAN MORNING BRIEFING : Stocks Waver, -3-
DJ
02/22NORTH AMERICAN MORNING BRIEFING : Stocks to Open -3-
DJ
01/20ODONATE THERAPEUTICS, INC.(NASDAQGS : ODT) dropped from S&P Global BMI Index
CI
01/20ODONATE THERAPEUTICS, INC.(NASDAQGS : ODT) dropped from S&P TMI Index
CI
01/17ODONATE THERAPEUTICS, INC.(NASDAQGS : ODT) dropped from NASDAQ Composite Index
CI
01/07Top Midday Decliners
MT
01/07Odonate Therapeutics Gets Nasdaq Notice to Delist Shares
MT
01/07ODONATE THERAPEUTICS : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - For..
PU
01/07ODONATE THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing..
AQ
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -126 M - -
Net cash 2020 152 M - -
P/E ratio 2020 -4,99x
Yield 2020 -
Capitalization 58,5 M 58,5 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 145
Free-Float 97,2%
Chart ODONATE THERAPEUTICS, INC.
Duration : Period :
Odonate Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ODONATE THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Managers and Directors
Kevin C. Tang Chairman & Chief Executive Officer
Michael S. Hearne Chief Financial Officer
Thomas Wei Chief Scientific Officer
Steven Pfeiffer Senior Vice President-Technical Operations
Kimberly Ma Senior Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
ODONATE THERAPEUTICS, INC.12.59%59
JOHNSON & JOHNSON4.53%470 547
PFIZER, INC.-13.06%288 063
ABBVIE INC.14.31%273 513
ELI LILLY AND COMPANY9.12%271 308
ROCHE HOLDING AG-14.97%263 868